Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$167,544,792
+$37,527,025 QoQ
Shares Held
139,687
-1.2% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
#290
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026USS Investment Management Ltd holds $724,325,860 across 10 Drug Manufacturers - General names. LLY ranks #2 (23.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,014,246 | $257,588,056 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
139,687 | $167,544,792 | |
| 3 | ABBV |
AbbVie Inc.
|
300,376 | $75,586,616 | |
| 4 | MRK |
Merck & Co., Inc.
|
432,343 | $55,556,075 | |
| 5 | AZN |
Astrazeneca PLC
|
255,043 | $48,361,253 | |
| 6 | AMGN |
Amgen Inc
|
96,817 | $35,059,372 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
225,951 | $28,546,649 | |
| 8 | PFE |
Pfizer Inc
|
999,888 | $24,077,303 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $167,544,792 | 139,687 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $130,017,767 | 141,359 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $147,613,759 | 137,356 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $104,819,414 | 137,378 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $107,090,272 | 137,378 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $112,396,440 | 136,088 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $123,299,208 | 159,714 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $142,284,621 | 160,603 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $147,441,133 | 162,850 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $126,667,447 | 162,820 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $94,470,929 | 162,065 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $96,793,511 | 180,205 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $84,264,919 | 179,677 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $62,322,144 | 181,475 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $63,010,818 | 172,236 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $63,274,421 | 195,684 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $82,950,030 | 255,837 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $83,362,020 | 291,099 | Shares | Sole | 2022-07-18 | |
| 2021-12-31 | $76,987,485 | 278,718 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $64,397,793 | 278,718 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $35,038,982 | 152,662 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $28,520,314 | 152,662 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $25,775,452 | 152,662 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $22,745,049 | 153,662 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $24,817,777 | 151,162 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $32,959,872 | 237,600 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||